ReviewCirculating endothelial cells: A novel marker of endothelial damage
Section snippets
Circulating endothelial cells — a historical perspective
Circulating endothelial cells (CECs) were first described over 30 years ago by Bouvier and Hladovec. Their techniques included vital light microscopy, Giemsa staining and separation by density centrifugation ([1], [2], [3], [4]). Increased numbers of circulating endothelial cells were also detected in animal models of shock, such as treatment with endotoxin ([3]). Between 1970 and 1980 studies in humans followed and these cells were identified in various conditions, such as smoking, acute
Immunomagnetic isolation of CECs
In healthy individuals the endothelial layer is continuously renewed at only a low replication rate of 0–1% per day. Endothelial proliferation is clustered at sites of branching [19] while laminar flow has been reported to suppress endothelial apoptosis [20]. The turnover of endothelial cells varies greatly in different organs. In accordance with these data, detection of circulating endothelial cells in a healthy adult is a rare event and immunomagnetic isolation has consistently yielded as few
Isolation of CECs by fluorescence-activated cell sorting (FACS)
Flow cytometry represents another attractive approach to isolate and enumerate CECs [29], [30], [31], [32], [33]. In general, multi-parametric flow cytometry is used to detect endothelial cells and discriminates them from cells with overlapping expression of antigens. For example, CD 146 expression on activated T cells can be distinguished from CD 146 on endothelial cells by co-staining with CD45 or CD3 (or both). CD 133 may help to identify EPCs because it is not present on CECs or any mature
CECs in vascular disorders
Numbers of CECs also reflect the extent of the endothelial lesion. High cell counts have been observed in diseases with widespread vascular damage, such as rickettsial infection, sickle cell disease or vasculitis [22]. In contrast, localized damage may be seen in patients undergoing coronary angioplasty and low cell numbers have been observed in this setting. In healthy subjects, renewal of the endothelial layer takes place at a low replication rate of 0–1% per day. Therefore, detection of
Phenotype and mechanisms of detachment of endothelial cells
The vascular network has an estimated surface area of more than 1000 m2 and maintains an anticoagulant, anti-thrombotic and anti-inflammatory state [78]. Endothelial cells can be activated by various stimuli, such as pro-inflammatory cytokines, growth factors, infectious agents, lipoproteins, or oxidative stress. Irreversible loss of integrity of the endothelial layer eventually leads to cell detachment. It must be noted that detached cells could be apoptotic or necrotic [79]. Unfortunately,
Interactions of circulating endothelial cells with other cell subsets
It is unknown whether circulating endothelial cells are pro-inflammatory [79]. Several products released by necrotic cells have been found to initiate an inflammatory response. These products include high mobility group 1 protein (HMGB1) [94], cytochromes, plasma DNA or heat shock proteins. Other studies have observed that necrotic but not apoptotic cells initiate a Toll-like-receptor-2/NF κB-dependent reaction in monocytes and fibroblasts [95]. The uptake of necrotic cellular material
CECs and other circulating markers of vascular damage
Endothelial cells express a broad variety of proteins [97] but only few of these have been studied in serum or plasma in vascular disease. Currently, von Willebrand factor (vWF), thrombomodulin and soluble E-selectin are best described [98], [99], [100], [101]. It must be noted that several factors may influence the levels of these circulating proteins. For example, thrombomodulin undergoes renal excretion. Hence, serum levels are influenced by renal function. Other confounding factors, such as
CECs and EPCs
CECs and EPCs represent two groups of non-hematopoietic cells in the blood. Agreement on the phenotypic differentiation of EPC and CEC is still lacking, not least because several markers occur on both. It is believed that CECs and EPCs have different origins. CECs derive from mature endothelium while EPCs derive from the bone marrow. Accordingly, EPCs are characterized by the expression of CD 34 and the receptor for vascular endothelial growth factor (VEGFR-2 or KDR/Flk-1) [108]. Many
Conclusion
Circulating endothelial cells are a novel marker of vascular damage. Cell numbers correlate with disease activity across a variety of diseases. Their use in a clinical setting is on the horizon and pathogenetic clues may also be obtained. The phenotype and functional capacity of these cells as well as interactions with other cell subsets need to be further elucidated. Another crucial issue is standardization of the technique, a task that has been addressed by a European multi-center effort. In
References (118)
Cell biology of endothelial cells
Hum Pathol
(1987)- et al.
Immunologic detection of endothelial cells in human whole blood
Blood
(1991) - et al.
Identification of the S-Endo 1 endothelial-associated antigen
Biochem Biophys Res Commun
(1996) - et al.
Identification of CD146 as a component of the endothelial junction involved in the control of cell–cell cohesion
Blood
(2001) - et al.
Activation of human endothelial cells via S-endo-1 antigen (CD146) stimulates the tyrosine phosphorylation of focal adhesion kinase p125 (FAK)
J Biol Chem
(1998) - et al.
Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever
Blood
(1993) - et al.
Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells
Blood
(1999) - et al.
Increased endothelial cell turnover in areas of in vivo Evans Blue uptake in the pig aorta
Atherosclerosis
(1973) - et al.
Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis
Lancet
(2003) - et al.
Visualization of live endothelial cells ex vivo and in vitro
Microvasc Res
(2003)
Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol
J Thromb Haemost
Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease
Kidney Int
Resting and activated endothelial cells are increased in the peripheral blood of cancer patients
Blood
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes
Blood
Circulating endothelial cells in renal transplant recipients
Transplant Proc
Endothelial cell chimerism after renal transplantation and vascular rejection
Lancet
Circulating endothelial cells as a marker of endothelial damage in allogeneic hematopoietic stem cell transplantation
Blood
Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients
Ann Oncol
Optimal biologic dose of metronomic chemotherapy regimens is associated with maximum antiangiogenic activity
Blood
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer
Neoplasia
Circulating endothelial cells as potential markers of the state of the endothelium in hemodialysis patients
Am J Kidney Dis
Circulating endothelial cells are associated with future vascular events in hemodialysis patients
Kidney Int
Endothelial cells in physiology and in the pathophysiology of vascular disorders
Blood
Circulating endothelial cells in cancer patients do not express tissue factor
Cancer Lett
Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaB
Biochem Biophys Res Commun
The role of nitric oxide in tissue destruction
Best Pract Res Clin Rheumatol
Circulating endothelium as an indication of vascular injury
Thromb Diath Haemorrh
Circulating endothelial cells in acute myocardial infarction and angina pectoris
Klin Wochenschr
Circulating endothelial cells and arterial endothelial mitosis in anaphylactic shock
Br J Exp Pathol
A technique for locating rare cells in the circulation for ultramicroscopy
Proc Soc Exp Biol Med
Stabilization of endothelial lining and decrease in circulating endothelial cells—one mechanism underlying the clinical action of PGE1?
Br J Clin Pharmacol
Decrease of endothelaemia during immunosuppression
Biomedicine
Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement
J Clin Invest
Rapid isolation of human endothelial cells from whole blood using S-Endo1 monoclonal antibody coupled to immuno-magnetic beads: demonstration of endothelial injury after angioplasty
Thromb Haemost
S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen
Tissue Antigens
Diagnosis of Mediterranean spotted fever by indirect immunofluorescence of Rickettsia conorii in circulating endothelial cells isolated with monoclonal antibody-coated immunomagnetic beads
J Infect Dis
Circulating activated endothelial cells in sickle cell anemia
N Engl J Med
Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells
Arterioscler Thromb Vasc Biol
Circulating endothelial cells. Biomarker of vascular disease
Thromb Haemost
An improved assay for enumeration of circulating endothelial cells
Ann Hematol
Comparison of Ulex europaeus I lectin binding and factor VIII-related antigen as markers of vascular endothelium in follicular carcinoma of the thyroid
Histopathology
Circulating endothelial cells in vascular disorders: new insights into an old concept
Eur J Haematol
Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement
J Am Soc Nephrol
Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis
Arthritis Rheum
Strategies to investigate circulating endothelial cells in cancer
Pathophysiol Haemost Thromb
Endothelial precursors and mature endothelial cells are increased in the peripheral blood of myelodysplastic syndromes
Leuk Lymphoma
Circulating endothelial cells as a novel marker of angiogenesis
Adv Exp Med Biol
Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis
Br J Cancer
Circulating endothelial precursors: mystery, reality, and promise
J Clin Invest
Cited by (130)
Effect of vasodilator and immunosuppressive therapy on the endothelial dysfunction in patients with systemic sclerosis
2023, Clinical and Experimental MedicineAre circulating endothelial cells the next target for transcriptome-level pathway analysis in ARDS?
2023, American Journal of Physiology - Lung Cellular and Molecular Physiology